Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cycloserine (250mg) Capsule
Therapeutic Category
Pulmonary, Respiratory, Antibacterials, Antibiotic
Dosage Form
Capsule
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cyclome 250 Capsule contains Cycloserine (250 mg), an effective second-line anti-tubercular agent used in the management of multi-drug resistant tuberculosis (MDR-TB). Cycloserine works by inhibiting bacterial cell wall synthesis, thereby controlling the growth of Mycobacterium tuberculosis.
It is typically prescribed as part of a combination therapy regimen for patients who do not respond to first-line anti-TB drugs. Regular monitoring is essential due to its neurotoxic potential, but its efficacy in resistant TB cases makes it a critical medicine.
Belonging to the anti-infective and tuberculosis segment, Cyclome 250 Capsule is in high demand in hospitals, clinics, and government TB programs. Its inclusion in MDR-TB treatment protocols ensures recurring demand in the healthcare sector.
For PCD pharma franchise partners, third-party manufacturers, and exporters, Cyclome 250 Capsule represents a profitable B2B opportunity. Its specialized therapeutic use guarantees strong market potential and long-term business sustainability across India.
Common side effects may include headache, dizziness, nausea, vomiting, and mild peripheral neuropathy. Rarely, severe neurological symptoms, seizures, or psychiatric effects may occur. Report any unusual neurological or psychiatric symptoms to your doctor immediately.
Cyclome 250 Capsule is indicated for the treatment of multidrug-resistant tuberculosis (MDR-TB), usually as part of a combination therapy regimen. It helps control the infection and prevents the spread of TB bacteria.
Take Cyclome 250 Capsule exactly as prescribed, usually on an empty stomach for better absorption. Regular monitoring of liver function, kidney function, and neurological status is essential during therapy. Inform your doctor if you have a history of epilepsy, kidney disease, or psychiatric disorders.
Store Cyclome 250 Capsule in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Tolperisone (150mg) + Paracetamol (325mg)
Composition : Thiocolchicoside (4mg) + Aceclofenac (100mg) + Paracetamol (325mg) Tablet
Composition : Tolperisone (150mg) + Diclofenac (50mg)
Composition : Tolperisone (450mg) + Diclofenac (100mg)
Composition : Trypsin I.P. 48mg + Bromelain B.P. 90mg + Rutoside Trihydrate B.P. 100mg + Diclofenac I.P. 50mg
Composition : Tamsulosin (0.4mg) + Dutasteride (0.5mg)
Composition : Silodosin (8mg) + Dutasteride (0.5mg)
Composition : Timolol (5mg) + Brimonidine (2mg) Eye Drop
Composition : Tobramycin (0.3% w/v) + Fluorometholone (0.1% w/v)
Composition : Tranexamic Acid (500mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Cycloserine 250mg Capsules have demand in the anti-tuberculosis (TB) segment, making them a specialized and high-value product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from its use in drug-resistant tuberculosis (MDR-TB/XDR-TB) treatment protocols under specialist supervision. It strengthens their anti-TB and specialized antibiotic portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Cycloserine I.P. 250mg Capsules with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from niche but stable institutional demand, government and hospital procurement opportunities, and long-term treatment-based consumption patterns when partnering in this segment.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this anti-tuberculosis formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.